期刊文献+

国外对贯叶连翘抗抑郁疗效的临床验证 被引量:16

Discussion on clinical efficacy of Hypericum perforatum for depression abroad
下载PDF
导出
摘要 贯叶连翘 (HypericumperforatumL .)在欧洲民间用于治疗创伤 ,近年来在欧美国家广泛用于治疗轻、中度抑郁症。临床试验表明该植物制剂的抗抑郁疗效优于传统化学合成药物 ,具有较好的耐受性与安全性。分子药理学与神经药理学的发展推动了贯叶连翘抗抑郁分子机制的研究 ,临床药代动力学和药效学的研究则为贯叶连翘的临床应用提供了可靠依据。贯叶连翘抗抑郁的临床疗效是显著的 ,可信的。 The development of molecular pharmacology and neuropharmacology accelerated the studies on molecular mechanism of Hypericum perforatum for depression. The clinical trials indicated that this galenical was superior to the traditional synthetic drugs for antidepression. This preparation had good tolerability and safety. Clinical pharmacokinetics and pharmacodynamics provided further evidence for clinical application of Hypericum. The clinical efficacy of Hypericum for depression was notable and credible.
出处 《中西医结合学报》 CAS 2004年第3期231-234,238,共5页 Journal of Chinese Integrative Medicine
基金 国家教育部高校骨干教师基金资助项目 (No .2 0 0 0 2 0 0 2 ) 广州市科技局重大资助项目 (No.1999 2 0 0 3 )
关键词 贯叶连翘 抑郁 药物治疗 中药 临床验证 Hypericum perforatum antidepression drug evaluation
  • 相关文献

参考文献40

  • 1[1]ESCOP. "Hyperici herba" monographs on the medicinal uses of plant drugs[M]. Exeter, U.K.: European Scientific Cooperative on Phytotherapy, 1997.
  • 2[2]Kleber E, Obry T, Hippeli S, et al. Biochemical activities of extracts from Hypericum perforatum L.. 1st communication: inhibition of dopamine-beta-hydroxylase[J]. Arzneimittelforschung, 1999, 49(2): 106-109.
  • 3[3]Thiede HM, Walper A. Inhibition of MAO and COMT by hypericum extracts and hypericin[J]. Psychiatry Neurol, 1994, 7(Suppl 1): S54-56.
  • 4[4]Denke A, Schneider W, Elstner EF. Biochemical activities of extracts from Hypericum perforatum L.. 2nd communication: inhibition of metenkephaline- and tyrosine-dimerization[J]. Arzneimittelforschung, 1999, 49(2): 109-114.
  • 5[5]Chatterjee SS, Bhattacharya SK, Wonnemann M, et al. Hyperforin as a possible antidepressant component of hypericum extracts[J]. Life Sci, 1998, 63(6): 499-510.
  • 6[6]Laakmann G, Jahn G, Schule C. Hypericum perforatum extract in treatment of mild to moderate depression. Clinical and pharmacological aspects[J]. Nervenarzt, 2002, 73(7): 600-612.
  • 7[7]Jensen AG, Hansen SH, Nielsen E. Adhyperforin as a contributor to the effect of Hypericum perforatum L. in biochemical models of antidepressant activity[J]. Life Sci, 2001, 68(14): 1593-1605.
  • 8[8]Linde K, Ramirez G, Mulrow CD, et al. St John's wort for depression--an overview and meta-analysis of randomised clinical trials[J]. BMJ, 1996, 313(7052): 253-258.
  • 9[9]Volz HP. Controlled clinical trials of Hypericum extracts in depressed patients--an overview[J]. Pharmacopsychiatry, 1997, 30(Suppl 2): 72-76.
  • 10[10]Laakmann G, Schule C, Baghai T, et al. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy[J]. Pharmacopsychiatry, 1998, 31(Suppl 1): 54-59.

同被引文献129

引证文献16

二级引证文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部